Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01875185 · ClinicalTrials.gov registry record · Phase 4
Hormones Inflammation and Thrombosis
A Phase 4 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT01875185: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.
NCT01875185 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01875185, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The investigators are attempting to determine if the response to aspirin in women is related to the level of estrogen and progesterone that a woman has.
Interventions
- DRUG Aspirin 81 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01875185
The ClinicalTrials.gov registry entry for NCT01875185 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aspirin 81 mg is the first listed.
NCT01875185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01875185 about?
NCT01875185 is a clinical study titled "Hormones Inflammation and Thrombosis". The investigators are attempting to determine if the response to aspirin in women is related to the level of estrogen and progesterone that a woman has.
What is the current status of trial NCT01875185?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2012-12. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01875185?
The interventions under investigation include: Aspirin 81 mg (DRUG).
Who is sponsoring clinical trial NCT01875185?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.